EPHA4 and pancreatic adenocarcinoma: Similarly, EphA4 has been reported to be upregulated in pancreatic adenocarcinoma cell lines; interestingly, knocking down EphA4 expression was associated with decreased proliferating capacity [21], highlighting its potential as a therapeutic target.